INTRODUCTION AND OBJECTIVES: Catheter-associated urinary tract infection (CAUTI) is a major preventable cause of harm in hospitalized patients. Previous in vitro studies have shon wthat a unique surface micropattern on catheter surface reduces bacterial biofilm formation. This single center, open labelled, randomized interventional study evaluated if the Sharklet micropatterned catheter (SC) reduces UTI in catheterized patients, when compared to a standard silicone Foley catheter. (NCT02835456) METHODS: Fifty eligible adult men requiring temporary urethral catheterization for a period between 3 and 30 days were randomized into two groups with standard silicone Foley catheter insertion in one and SC in other. On removal, parts of the catheters (tip, middle part and base) were examined for bacterial colonization/biofilm using scanning electron microscopy. The patients were also assessed for incidence of symptomatic UTI, significant asymptomatic bacteriuria, pain and discomfort.
RESULTS: The mean age and duration of catheterization were similar among both groups. None of the patients developed symptomatic CAUTI. The outer surface of the SC had significantly lower biofilm formation when compared to the standard silicone catheter in all parts of the catheter (Tip: P¼ 0.003, Middle part: P¼0.013 and Base: P¼0.013). However, this difference was not noted in the inner surface of the catheters (P¼ 0.511, P¼0.245, P¼0.810 respectively); which may be attributed to the absence of micropattern in the inner surface of SC. There was significantly lower pain and discomfort in patients using SC when compared to the standard catheter (p¼0.018).
CONCLUSIONS: Catheters that can reduce CAUTI have the advantage of improving the care of millions of disabled and elderly patients and reducing the enormous costs of managing complications associated with indwelling Foley catheter. However, none of the numerous strategies tested until now, like antibiotic or silver impregnation on catheter surface have proved to be useful in this regard. This is the first trial to test the efficacy of Sharklet micropattern on urinary catheter surface in a clinical setting. The promising results of this study opens the arena for novel mechanical modifications on catheter surface which may be both cost effective and clinically beneficial. METHODS: Telephone survey and chart review of men with sperm FISH testing and semen analysis was performed. Male age, female age, and female reproductive factors were recorded for each live birth, SAB, and IF. Sperm aneuploidy was defined using FISH, which examines autosomes 13, 18, 21, and the sex chromosomes. We performed linear regression to assess the impact of sperm aneuploidy FISH results on pregnancy outcomes.
RESULTS: Data were collected from 99 men with 434 reproductive outcomes. Of 99 sperm FISH tests, 94 were abnormal. MeanAESD male age was 37.1AE7.3 years, female age was 33.4AE5.0 years, and length of infertility was 47.4AE33.9 months. Total number of abnormal FISH components (range 0-4, with each chromosomal abnormality considered an abnormal FISH component) was found to best model SAB risk. Controlling for female age and semen parameters, the total number of abnormal FISH components significantly predicted SABs (p¼0.001). Each additional abnormal FISH component increased the risk of SAB by 9.33% (p¼0.001) for all reproductive outcomes. When only pregnancies achieved through natural conception were considered, the risk of SAB increased by 10.4% with each abnormal FISH component (p¼0.003). Female age approached significance in both models; each year increased the risk of SAB by 1.2% (p¼0.081). Sperm disomy, male age, female reproductive factors, semen volume, sperm density, and sperm motility did not predict SABs (p>0.05) ( Figure  1 ). Abnormal FISH testing did not predict IF (p¼0.259). The overall pregnancy rate in men with abnormal sperm FISH was 0.95% using IUI, 10.2% using IVF, 14.8% using IVF/ICSI, and 50% when preimplantation genetic screening (PGS) was added to IVF.
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